Abstract: Surgery is the cornerstone of treatment of ovarian cancer. Given the importance of achieving no or minimal macroscopic residual disease at primary surgery, performing an assessment of the quality of ovarian cancer surgery is crucial. Assessing the quality of care and surgical outcome allows us to establish baseline information, set standards of care and clear priorities, enable benchmarking against peers, and sustain quality improvement. We know that suboptimal care exists and variation in outcomes results. One way to monitor variation in outcomes is through a clinical quality registry (CQR). A CQR collects a defined minimum dataset to measure performance of an individual or center against a range of clinical quality indicators and provides risk-adjusted, benchmarked data to participating institutions. CQR’s are an excellent quality assurance measure as they capture all cases (an opt out system). They permit detection and analysis of unwarranted variations in care. This can provide indications of a systems or process problem, thereby motivating health care providers to improve services and care. Several groups have either developed quality indicators for advanced ovarian cancer surgery (The Scottish Cancer Taskforce and the European Society of Gynecological Oncology) or are in the process of doing so (Australian Society of Gynaecological Oncologists). Indicators should be evidence-based and determined by extensive discussion with experts and stakeholders to ensure appropriateness and buy-in. The Scottish Cancer Taskforce and European Society of Gynecological Oncology have set targets for their quality performance measures, which should provide a quantitative framework for improving care in the surgical management of ovarian cancer.

Abstract: Ferrous sulphate is an inorganic salt of iron used to treat iron deficiency anaemia and maintain the overall health in our body. The current study was designed to evaluate the impact of The Trivedi Effect®-Energy of Consciousness Healing Treatment on the physicochemical and thermal properties of ferrous sulphate using PXRD, PSA, DSC, and TGA/DTG analysis. Ferrous sulphate test item was divided into two parts, one part was considered as control (without Biofield Energy Treatment), whereas the second part received The Trivedi Effect®-Biofield Energy Treatment remotely by the renowned Biofield Energy Healer, Alice Branton. The PXRD data revealed that the relative intensities and crystallite size of the characteristic diffraction peaks in the treated sample were significantly altered from -26.74% to 421.23% and from -24.93% to 42.91%, respectively compared with the control sample. The average crystallite size of the treated sample was significantly increased by 6.39% compared to the control sample. The particle size values at d10, d50, d90 and D(4, 3) values were significantly increased by 30.43%, 35.94%, 19.49%, and 26.26%, respectively and the surface area was significantly decreased by 53.26% compared with the control sample. The melting temperature of the treated sample in the 1st and 3rd peaks was increased by 1.61% and 1.04% respectively, whereas decreased by 5.71% and 1.04% in the 2nd and 4th peaks, respectively compared with the control sample. Consequently, the total latent heat of fusion to transition from FeSO4•7H2O to FeSO4 was decreased by 0.44% in the treated sample compared with the control sample. The TGA thermograms of both the samples exhibited four steps of thermal degradation. The total weight loss in the treated sample was increased by 0.62% compared with the control sample. The maximum thermal decomposition temperature (Tmax) of treated sample was increased by 5.81% and 0.26% in the 1st and 4th peak respectively, but the Tmax of 2nd and 3rd peaks were decreased by 2.58% and 2.38%, respectively compared to the control sample. Overall, DSC and TGA/DTG of the treated sample showed that the thermal stability was changed compared with the control sample. The Trivedi Effect®-Consciousness Energy Healing Treatment might lead to the production of a polymorphic form of ferrous sulphate, which would have better powder flowability and appearance with altered thermal stability compared to the control sample. Alice’s Biofield Energy Treated ferrous sulphate would be useful to design better nutraceutical/pharmaceutical formulations, which could provide better therapeutic response against iron deficiency anaemia.

Abstract: There are numerous scientific studies on vitamin D3 reported to have many important roles viz. in bone metabolism, osteoporosis, immunity, and useful in several diseases, e.g., cancers, cardio-vascular, and neurodegenerative diseases. Surprisingly, there is little information available about the concentration of 25-hydroxyvitamin D3 in the blood, which is the best indicator of vitamin D3 status after its oral absorption. However, the biological activity of vit-D3 is mediated via the formation of the active metabolite, 1-α, 25-dihydroxyvitamin D3. There are several factors which affect its absorption and first-pass metabolism that lead to have very low plasma concentrations of both the metabolites (25-hydroxyvitamin D3 and 1-α, 25-dihydroxyvitamin D3) following an oral administration. Therefore, the present study was performed to determine the effects of The Trivedi Effect®-Energy of Consciousness Healing Treatment on vit-D3 and rats through the measurement of plasma 25-hydroxyvitamin D3 concentrations after the oral administration of vit-D3 in rats. The test item, vit-D3 was divided into two parts. One part was denoted as the control (without Biofield Energy Healing Treatment), while the other part was defined as the Biofield Energy Treated sample, which received the Biofield Energy Healing Treatment by renowned Biofield Energy Healer, Alice Branton. Additionally, one group of animals also received Consciousness Energy Healing Treatment per se by the Healer under similar conditions. Vitamin D3 oral formulations were administrated by oral gavage at a dose of 500 µg per kg in groups viz. G1 (untreated Vitamin D3), G2 (Biofield Treated Vitamin D3) and G3 (Biofield Treated animals received untreated Vitamin D3) group. The Biofield Energy Healing Treatment significantly altered the relative oral exposure (AUC0–t) of 25-hydroxyvitamin D3 by 54.62% in G2 group compared to the control group, G1. The Biofield Energy Treatment also altered plasma peak concentration (Cmax) of 25-hydroxyvitamin D3 by 53.8% and 7.6% in G2 and G3 groups, respectively compared to the control group. After oral administration, plasma concentrations of 25-hydroxyvitamin D3 in control group (G1) declined with slow excretion rate and the elimination half-life (T1/2) was 100.59 hours. The oral elimination half-life (T1/2) of 25-hydroxyvitamin D3 in G2 and G3 were 69.09 hours and 55.76 hours, respectively. The mean residence time (MRTlast) and elimination rate constant (Kel) remained unaltered in all three groups. The Trivedi Effect®-Energy of Consciousness Healing Treatment could be an innovative strategy which opens new avenues to overcome poorly absorbed pharmaceuticals/nutraceuticals/herbal extracts and can improve the therapeutic performance of orally active molecules.

Abstract: Magnesium gluconate is usually used as a dietary supplement for the prevention and treatment of hypomagnesemia as well as to maintain the overall quality of life. The present study was designed to evaluate the impact of The Trivedi Effect®-Energy of Consciousness Healing Treatment on the physicochemical and thermal properties of magnesium gluconate using PXRD, PSA, DSC, and TGA/DTG analysis. Magnesium gluconate was divided into two parts – one part was control (without Biofield Energy Treatment), while another part was treated with Energy of Consciousness Healing Treatment (The Trivedi Effect®) remotely by the renowned Biofield Energy Healer, Alice Branton and defined as Biofield Energy Treated sample. The PXRD analysis showed that the relative peak intensities and crystallite sizes of the characteristic diffraction peaks in the treated sample were significantly altered from -73.55% to 17.21% and from -14.28% to 125.11%, respectively compared with the control sample. The average crystallite size was significantly increased by 19.29% in the treated sample compared to the control sample. The particle size values at d10, d50, d90, and D(4, 3) of the treated sample was significantly increased by 2.03%, 70.92%, 142.25%, and 95.42%, respectively compared with the control sample. Thus, the surface area of treated sample was significantly decreased by 21.34% compared to the control sample. The melting point of the Biofield Energy Treated sample (170.16°C) was decreased by 0.19% compared the control sample (170.48°C). The latent heat of fusion in the treated sample was increased by 3.11% compared to the control sample. The TGA analysis exhibited three steps thermal degradation and the total weight loss of the treated sample was increased by 0.29% compared to the control sample. The maximum thermal degradation temperatures (Tmax) of the 1st and 2nd peaks were decreased by 2.86% and 1.97%, respectively, while 2nd and 3rd peaks were increased by 1.14% and 0.94% respectively, in the treated sample compared to the control sample. The thermal analysis revealed that the thermodynamic stability of the treated sample was changed compared with the control sample. The Energy of Consciousness Healing Treatment might produce a crystalline polymorphic form of magnesium gluconate, which could show better powder flowability and appearance with altered thermal stability compared to the untreated sample. Hence, Biofield Energy Treated magnesium gluconate would be advantageous in designing better nutraceutical/pharmaceutical formulations that might provide better therapeutic responses against inflammatory diseases, immunological disorders, cancer, diabetes mellitus, stress, aging, etc.

Abstract: Berberine, an isoquinoline alkaloid based herbal medicine, is widely used as nutraceutical supplement for the prevention and treatment of various diseases viz. hypolipidemic, hypoglycemic, antiarrhythmic, antineoplastic, etc. The intestinal absorption and oral bioavailability of berberine is very low and almost negligible in humans. In this study, the relative oral bioavailability of berberine was studied, and the effects of The Trivedi Effect®-Energy of Consciousness Healing Treatment on animals and berberine were investigated through the measurement of plasma concentrations after oral administration in rats. The test item, berberine chloride was divided into two parts. One part was denoted as the control without any Biofield Energy Healing Treatment, while the other part was defined as the Biofield Energy Treated sample, which received the Biofield Energy Healing Treatment by renowned Biofield Energy Healer, Alice Branton. Additionally, one group of animals also received Consciousness Energy Healing Treatment per se by Alice under similar conditions. Berberine oral formulations were made and administrated by oral gavage at a dose of 150 mg per kg in groups viz. G1 (untreated berberine), G2 (Biofield Treated berberine) and G3 (Biofield Treated animals were received untreated berberine) group. The results showed that berberine had a very low oral plasma exposure of 179.92 ng/mL in the control group. The Biofield Energy Healing Treatment significantly enhanced the relative oral exposure (AUC0–t) of berberine by 233.40% and 35.62% in G2 and G3 groups, respectively compared to the control group. The Biofield Energy Treatment also improved plasma peak concentration (Cmax) of berberine by 37.7 and 1.4 times, in G2 and G3 groups, respectively compared to the control group. The absorption rate constant (Ka) of berberine in Biofield Energy Treatment group significantly increased by 100% (p < 0.05) in G2 group as compared to the control group (G1). The apparent oral plasma clearance of berberine decreased significantly (p < 0.01) by 81%, and 50% in G2 group and G3 group, respectively as compared to the control group. The enhanced bioavailability of berberine might be due to the alteration its physicochemical properties and thermal properties by Biofield Energy Treatment. Biofield Energy Healing Treatment is considered as an innovative strategy which opens new avenues to overcome poorly absorbed drug/nutraceuticals/herbal extracts and can also improve the therapeutic performance of orally active molecules. Thereby, the Biofield Energy Treated berberine chloride having improved bioavailability can significantly increase in antibacterial, anticancer, antidiabetic, anti-obesity, anti-ischemia, memory and cognition, inhibition of metabolic syndrome and neurodegenerative diseases.